S100A8 /S100A9

7
S100A8 /S100A9 Relative DIGE MEASUREMENTS F KD FI SJIA APOA1 SAP CRP HP S100A9 SAA S100A8 A2M Q Figure 4 F KD FI SJIA APOA1 SAP CRP HP SAA A2M Q Relative ELISA MEASUREMENTS

description

SJIA. SJIA. F. Q. KD. FI. F. Q. KD. FI. Relative DIGE MEASUREMENTS. Relative ELISA MEASUREMENTS. A2M. APOA1. CRP. HP. S100A9. S100A8. SAA. SAP. A2M. APOA1. CRP. HP. S100A8 /S100A9. SAA. SAP. Figure 4. C. A. B. D. Training set n = 24. Testing set n = 20. - PowerPoint PPT Presentation

Transcript of S100A8 /S100A9

Page 1: S100A8 /S100A9

S100A8/S100A9

Rela

tive

DIG

E M

EASU

REM

ENTS

F KD FISJIA

APOA1 SAPCRP HP S100A9 SAAS100A8A2M

Q

Figure 4

F KD FISJIA

APOA1 SAPCRP HP SAAA2M

Q

Rela

tive

ELIS

A M

EASU

REM

ENTS

Page 2: S100A8 /S100A9

A

Biomarker panelof 7 members

1. A2M

2. APO AI

3. CRP

4. HP

5. S100A8/S100A9

6. SAA

7. SAP

Training setn = 24

12 12

Clinicaldiagnosis F Q

n =

LDA

11 1

1 11

Classified as F

Classified as Q

PercentAgreementwith clinical

diagnosis

91.6% 91.6%+ -

91.6%

Overall

P = 1.0 E -4

Testing setn = 20

10 10

Clinicaldiagnosis F Q

n =

Testing

8 3

2 7

Classified as F

Classified as Q

PercentAgreementwith clinical

diagnosis

80% 70%+ -

75%

Overall

P = 7 E -2

C D

SJIA SJIA

BTraining

SJIA F SJIA Q SJIA F SJIA Q

Testing

Pred

icte

d pr

obab

ilitie

sPatient samples

Figure 5

P*= 9.6E -6 P*=4 E -3

Page 3: S100A8 /S100A9

E

CRP : AUC=0.82panel : AUC=0.95

ESR : AUC=0.96

Sen

sitiv

ity

S100A8/S100A9 : AUC=0.73

1- Specificity

CRP : AUC=0.65panel : AUC=0.82

ESR : AUC=0.86

Sen

sitiv

ity

S100A8/S100A9 : AUC=0.78

1- Specificity

Sen

sitiv

ity

CRP : AUC=0.72panel : AUC=0.94

ESR : AUC=0.92S100A8/S100A9 : AUC=0.74

1- Specificity

Training Set Testing Set Training + Testing Set

Figure 5

Page 4: S100A8 /S100A9

Training setn = 23

13 10

Clinicaldiagnosis F Q

n =

LDA

10 5

3 5

Classified as F

Classified as Q

PercentAgreementwith clinical

diagnosis

76.9% 50%+ -

65.2%

Overall

P = 0.41

Testing setn = 15

10 5

Clinicaldiagnosis F Q

n =

Testing

3 0

7 5

Classified as F

Classified as Q

PercentAgreementwith clinical

diagnosis

30% 100%+ -

53.3%

Overall

P = 0.20

B C

POLY POLY

D

1- Specificity

CRP : AUC=0.64

POLY F vs. Q

panel : AUC=0.64

Sen

sitiv

ity

ATraining

PF PQ PF PQ

Testing

Pred

icte

d pr

obab

ilitie

s

Patient samples

Supplementary Figure 5

Page 5: S100A8 /S100A9

Figure 6

Training setn = 59

22 37

Clinicaldiagnosis

n =

LDA

16 3

6 34

PercentAgreementwith clinical

diagnosis

72.8% 91.9%+ -

84.7%

Overall

P = 4.3E -7

SJIAF

1022 27

SJIAF KD + FI

NOTSJIA F

Classified as SJIA F

Classified as NOT SJIA F

A. Pr

edic

ted

prob

abili

ties

Patient samples

SJIA FKD FI

KD + FI

B

CRP : AUC=0.627panel : AUC=0.801

ESR : AUC=0.661

Sen

sitiv

ity

S100A8/S100A9 : AUC=0.543

1- Specificity

Page 6: S100A8 /S100A9

5 10

Clinicaldiagnosis QF QQ

n =

LDA

4 0

1 10

Classified as QF

Classified as QQ

PercentAgreementwith clinical

diagnosis

80% 100%+ -

93.3%

Overall

P = 3.7 E -3

BSJIA

C

CRP : AUC=0.82panel : AUC=0.90

ESR : AUC=0.68

A

Pred

icte

d pr

obab

ilitie

s

Patient samples

QQ QF

Sen

sitiv

ity

1- Specificity

S100A8/S100A9 : AUC=0.74

Figure 7

Page 7: S100A8 /S100A9

Figure 8